Curated News
By: NewsRamp Editorial Staff
January 15, 2026
SBC Medical Group Enters U.S. Market with OrangeTwist Investment
TLDR
- SBC Medical Group gains a strategic foothold in the lucrative U.S. medical aesthetics market by investing in OrangeTwist, leveraging its network for accelerated growth and market leadership.
- SBC Medical Group's investment initiates a multi-phase expansion plan, starting with joint operations and management synergies with OrangeTwist to scale in the U.S. and Southeast Asia.
- This partnership aims to bring high-quality, non-invasive aesthetic care to more communities globally, enhancing access to treatments with minimal risk and downtime.
- A Japanese medical group with 258 clinics worldwide is now partnering with a U.S. medspa chain, targeting a market projected to grow to $48 billion by 2030.
Impact - Why it Matters
This news matters because it signals a significant shift in the global medical aesthetics industry, with a major Japanese player expanding into the lucrative U.S. market, potentially increasing competition and innovation in non-invasive treatments. For consumers, this could lead to more accessible and diverse aesthetic options, driven by SBC's global expertise and OrangeTwist's established U.S. presence. The projected growth of the industry to $48 billion by 2030 highlights rising demand, influenced by aging populations and preferences for low-risk procedures, making this expansion relevant for anyone interested in healthcare trends, investment opportunities, or personal wellness. Additionally, SBC's parallel moves in Southeast Asia suggest a broader trend of cross-border healthcare collaborations, which could reshape service standards and availability in emerging markets.
Summary
SBC Medical Group Holdings Inc., a Japanese aesthetic medical clinic chain with 258 affiliated clinics worldwide and over six million annual patient visits, has officially entered the U.S. market through a strategic investment in OrangeTwist, a U.S.-based medspa chain specializing in non-invasive aesthetic treatments. This partnership marks the beginning of SBC's "full-scale" expansion strategy, leveraging OrangeTwist's 24 locations across six states and its advanced management system that integrates procurement, clinical workflows, and real-time KPI tracking. The collaboration will focus on joint operations, selling each other's services and products in the U.S. and Japan, and developing new beauty products and services, with SBC CEO Yoshiyuki Aikawa highlighting OrangeTwist's leadership in delivering exceptional quality and client experiences in non-invasive aesthetic medicine.
The investment represents Phase One of SBC's multiyear roadmap to establish a leading position in the medical aesthetics and wellness market, targeting international expansion in the U.S. and Southeast Asia. The U.S. market is particularly strategic, with the medical aesthetics industry projected to grow from $34 billion to $48 billion by 2030, driven by demand for injectables, fillers, laser treatments, and body contouring, as well as an aging population seeking aesthetic treatments with minimal risk and downtime. In 2026, SBC plans additional strategic investments and partnerships, following its recent e-consulting agreement with BLEZ ASIA Co. Ltd. in Thailand, which operates over 20 pharmacies and clinics and is preparing to open a new dermatology-focused clinic in Bangkok with SBC's management support.
Phase Two of SBC's plan, slated for 2027-2028, will involve select acquisitions and joint ventures to accelerate growth, while Phase Three, starting in 2029, aims to achieve leadership positions in the U.S., Southeast Asia, and other key markets. This expansion strategy underscores SBC's commitment to leveraging global expertise and networks, as emphasized by OrangeTwist CEO Robert Settembro, who noted the partnership will bring exceptional aesthetic experiences to more communities. For more details on SBC Medical Group's plans, readers can click here, and the original content is available on Benzinga, with further disclosures accessible through the provided links.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, SBC Medical Group Enters U.S. Market with OrangeTwist Investment
